Literature DB >> 20934410

Aquaporin 4 expression in control and epileptic human cerebral cortex.

Valentina Medici1, Carolina Frassoni, Laura Tassi, Roberto Spreafico, Rita Garbelli.   

Abstract

Aquaporin-4 (AQP4), the prominent water channel in the brain, is particularly concentrated in astrocytic endfeet membranes lining the capillaries and the pia. This localisation pattern makes it well suited to regulate the flow of water and the homeostasis of the interstitial fluid surrounding the neurons. Using immunocytochemical and Western blot techniques, we investigated the expression of AQP4 and some related proteins (i.e. glial fibrillary acidic protein, glial glutamate transporter 1, the endothelial marker CD34, and dystrophin) in tissue taken from epileptic patients. To this end, we used surgical samples containing focal cortical dysplasia (FCD) Type IIB, samples of normal-appearing (cryptogenic) cortex, and samples from non-epileptic patients as controls. AQP4 expression and distribution in the cryptogenic patients were similar to those observed in the control cases, mainly concentrated around blood vessels. In the patients with FCD type IIB, severe malformation in cortical development, the protein was more expressed and the distribution pattern of AQP4 immunoreactivity was different, being strong in the neuropil and around several dysplastic neurons, whereas the vessels appeared to be less intensely stained by AQP4 and dystrophin. As the efficiency of AQP4 in regulating water and ion homeostasis in extracellular space depends on its spatial distribution in astrocytes, the different distribution of AQP4 protein in the FCD type IIB samples may modify fluid homeostasis control and the regular functioning of neuronal cells.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20934410     DOI: 10.1016/j.brainres.2010.10.005

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

1.  Inflammation in the developing rat modulates astroglial reactivity to seizures in the mature brain.

Authors:  Zuzanna Setkowicz; Emilia Kosonowska; Krzysztof Janeczko
Journal:  J Anat       Date:  2017-06-09       Impact factor: 2.610

Review 2.  Epilepsy related to developmental tumors and malformations of cortical development.

Authors:  Eleonora Aronica; Peter B Crino
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

3.  Different aquaporin-4 expression in glioblastoma multiforme patients with and without seizures.

Authors:  Gianluca Isoardo; Isabella Morra; Giulia Chiarle; Valentina Audrito; Silvia Deaglio; Antonio Melcarne; Carola Junemann; Michele Naddeo; Maurizio Cogoni; Maria Consuelo Valentini; Andrea Limberti; Federico Faccani; Fabio Malavasi; Giuliano Faccani
Journal:  Mol Med       Date:  2012-09-25       Impact factor: 6.354

Review 4.  Role of astrocytes in epilepsy.

Authors:  Douglas A Coulter; Christian Steinhäuser
Journal:  Cold Spring Harb Perspect Med       Date:  2015-03-02       Impact factor: 6.915

Review 5.  Breakdown of blood brain barrier as a mechanism of post-traumatic epilepsy.

Authors:  Aaron Dadas; Damir Janigro
Journal:  Neurobiol Dis       Date:  2018-07-18       Impact factor: 5.996

6.  The role of astroglia in the epileptic brain.

Authors:  Gabriele Losi; Mario Cammarota; Giorgio Carmignoto
Journal:  Front Pharmacol       Date:  2012-07-12       Impact factor: 5.810

Review 7.  Novel astrocyte targets: new avenues for the therapeutic treatment of epilepsy.

Authors:  Vincenzo Crunelli; Giorgio Carmignoto; Christian Steinhäuser
Journal:  Neuroscientist       Date:  2014-03-07       Impact factor: 7.519

8.  Early Gabapentin Treatment during the Latency Period Increases Convulsive Threshold, Reduces Microglial Activation and Macrophage Infiltration in the Lithium-Pilocarpine Model of Epilepsy.

Authors:  Alicia Rossi; Veronica Murta; Jerónimo Auzmendi; Alberto Javier Ramos
Journal:  Pharmaceuticals (Basel)       Date:  2017-11-28

Review 9.  Human astrocytes in the diseased brain.

Authors:  Elena Dossi; Flora Vasile; Nathalie Rouach
Journal:  Brain Res Bull       Date:  2017-02-13       Impact factor: 4.077

10.  Acetazolamide Suppresses Multi-Drug Resistance-Related Protein 1 and P-Glycoprotein Expression by Inhibiting Aquaporins Expression in a Mesial Temporal Epilepsy Rat Model.

Authors:  Lei Duan; Qing Di
Journal:  Med Sci Monit       Date:  2017-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.